Our industry-recognized Education team is committed to sharing program findings, best practices, insights, and trends from our educational programs across a range of therapeutic areas. These findings are regularly published in peer-reviewed journals, as well as presented at medical, patient, and industry conferences.
The 2022 ASCO Annual Meeting is a place where cutting-edge research spanning all major disease sites comes together so leaders in the field can stay up-to-date on clinical trials, the latest findings, and global perspectives on oncology innovations. We are especially excited to have two accepted e-abstracts at the 2022 ASCO...
Digital Education Tackles Competency Gaps in Understanding Gene and Cell Therapy The proliferation of gene and cell therapies is transforming medical care for many previously untreatable conditions. This brings a steep learning curve for clinicians seeking to understand the science, identify and counsel patients who are good candidates for this...
Aligned Education Fosters Better Understanding Between Patients and Providers Download the E-Poster here. The 2022 American Society of Pediatric Hematology/Oncology (ASPHO) Conference brings together hematology/oncology professionals for premier education and networking. We're pleased to share that the conference has accepted our poster abstract "Impact of Patient-Provider Initiative on Treatment of...
Researchers from around the world will soon convene at the SITC Tumor Immune Microenvironment: A Holistic Approach to explore the latest breakthroughs in immunotherapy. PlatformQ Health is pleased to be presenting a poster at the event highlighting impressive outcomes from its recent CME program "Incorporating Checkpoint Inhibitors into Cancer Care:...
Poster Presentation The Power of Education to Debunk Myths and Misconceptions about Clinical Trial Participation Among People with Diverse Racial and Ethnic Backgrounds The 2022 Alliance Industry Summit (ASI) will feature our poster about the power of education to debunk myths and misconceptions about clinical trial participation among people from...
Aligned Education Improves Patient Outcomes Across CME Programs The American Academy of Neurology's Annual Conference kicks off on April 2, 2022 in Seattle, featuring exclusive neurology science and education. We're pleased to share that PlatformQ Health has three posters published at the event, highlighting the outcomes of three aligned patient/provider...
Immune checkpoint inhibitors have brought tailored treatments for patients with a variety of cancers. This is changing the face of treatment and the practice patterns clinicians have for everything from diagnosis to testing, adverse event management, and survivorship care. To help clinicians prepare for these changes, PlatformQ Health and the...
Advances in disease-modifying therapies for multiple sclerosis can improve the quality of life of patients - yet rapid changes to the treatment landscape left knowledge gaps among providers and patients. In addition, for patients to play a role in their own making, they also need to understand treatment options, side...
Emerging treatments such as anti-GD2 therapies are improving outcomes for children with relapsed/refractory, high-risk neuroblastoma. The changing therapeutic landscape has left knowledge gaps, with clinicians needing assistance with understanding how to integrate new agents, administer new treatments, and manage associated side effects. To address these issues, PlatformQ Health teamed up...
For many people suffering from rare diseases, the diagnostic odyssey is far too long. Nearly 1 in 13 people are living with an undiagnosed condition, and it typically takes five years or longer to receive the correct diagnosis. Consistent clinician and patient education about rare diseases is crucial for helping...
The Accreditation Council for Continuing Medical Education reports that approximately 1,680 accredited education providers offered more than 170,000 educational activities in the past year alone, yet many providers lack the ability to track the effectiveness of the programs. Assessing the actual outcomes of continuing medical education (CME) is essential. That...
The pandemic has left clinicians who offer anti-VEGF therapy challenged to incorporate new procedures into clinical practice amid the need to add screening strategies to reduce transmission risk. To support U.S. retinal specialists and ophthalmologists who deliver anti-VEGF therapy to patients with diabetic retinopathy, diabetic macular edema, neovascular age-related macular...